- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07382934
Prevalence of Radix Entomolaris and Middle Mesial Canal in an Egyptian Sub-population Using Cbct. (RE MMC CBCT)
January 26, 2026 updated by: Ali Ayman Ali, Cairo University
Prevalence of Radix Entomolaris and Middle Mesial Canal in Lower Permanent Molars in an Egyptian Sub-Population Using CBCT: Cross Sectional Study
The aim of the study is to determine the prevalence of RE and MMCs in mandibular first and second molars among an Egyptian sub- population.
Study Overview
Status
Not yet recruiting
Conditions
Detailed Description
Primary Objective is to determine the prevalence of RE and MMC in mandibular molars within an Egyptian sub_population using CBCT analysis.
Study Type
Observational
Enrollment (Estimated)
395
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Egyptian sub-population
Description
Inclusion Criteria:
- Participants aged 18 years and above.
- Egyptian individuals with permanent mandibular molars had CBCT imaging.
- High-quality CBCT scans with clear visualization of mandibular molars.
Exclusion Criteria:
- Non- Egyptian patients.
- Molars are badly broken down with root defect such as root caries, or root resorption.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Lower Permanent Molars in an Egyptian Sub- Population
Egyptian Sub- Population
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prevalence of Radix Entomolaris in Lower Permanent Molars
Time Frame: 1 year
|
frequency and percentage of the prevalence of Radix Entomolaris
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prevalence of Middle Mesial Canal in Lower Permanent Molars in an Egyptian Sub- Population Using CBCT: Cross Sectional Study.
Time Frame: 1 year
|
Using CBCT to determine the prevalence of and Middle Mesial Canal frequency and prevalence in Lower Permanent Molars.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Talabani RM, Abdalrahman KO, Abdul RJ, Babarasul DO, Hilmi Kazzaz S. Evaluation of Radix Entomolaris and Middle Mesial Canal in Mandibular Permanent First Molars in an Iraqi Subpopulation Using Cone-Beam Computed Tomography. Biomed Res Int. 2022 Jul 11;2022:7825948. doi: 10.1155/2022/7825948. PMID: 35860794; PMCID: PMC9293536.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
February 1, 2026
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
September 1, 2026
Study Registration Dates
First Submitted
January 26, 2026
First Submitted That Met QC Criteria
January 26, 2026
First Posted (Actual)
February 3, 2026
Study Record Updates
Last Update Posted (Actual)
February 3, 2026
Last Update Submitted That Met QC Criteria
January 26, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- ENDO1-1-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.